ARIMIDEX Tablets
Prescribing Information for ARIMIDEX Tablets — PDF Document (786 KB)
Viewing the Prescribing Information requires Adobe Acrobat Reader. Download Adobe Acrobat Reader.
ARIMIDEX is indicated for adjuvant treatment of postmenopausal women with hormone receptor-positive early breast cancer.
ARIMIDEX is indicated for first-line treatment of postmenopausal women with hormone receptor-positive or hormone receptor-unknown locally advanced or metastatic breast cancer and for the treatment of advanced breast cancer in postmenopausal women with disease progression following tamoxifen therapy. Patients with estrogen receptor-negative disease and patients who did not respond to previous tamoxifen therapy rarely responded to ARIMIDEX.